In in vivo studies, gamabufotalin suppressed the tumor weight and size with the decreasing protein levels of COX-2 and phosphorylated p65 NF-κB in the tumor tissues of xenograft mice [62]. This evidence concerns the gene NFKB1 and neoplasm.